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Vilhjalmur Rafnsson, Olafur Ingimarsson, Ingimar Hjalmarsson,
Holmfridur Gunnarsdottir
Abstract
Objectives—The possibility of an associ-
ation between exposure to silica and
autoimmune diseases has recently come
under discussion. In the following case-
referent study, a cohort exposed to dia-
tomaceous earth and cristobalite provided
an opportunity to evaluate such an expo-
sure with reference to sarcoidosis.
Methods—The inhabitants of a district
served by a single healthcare centre and a
hospital formed the study base. A dia-
tomaceous earth plant is located in this
community and the medical institutions
are responsible for primary and second-
ary health care of the population. Cases of
sarcoidosis were identified from the hos-
pital records according to certain clinical,
radiological, and histological criteria.
Referents were selected randomly from
the population of the district. Information
on exposure to crystalline silica, cristobal-
ite, was obtained by record linkage of the
cases and referents with a file which
included all present and past workers at
the diatomaceous earth plant and those
who had worked at loading vessels with the
product from the plant.
Results—Eight cases of sarcoidosis were
found, six of which were in the exposed
group. Of the 70 referents, 13 were
exposed. The odds ratio (95% confidence
interval) was 13.2 (2.0 to 140.9).
Conclusion—The odds ratios were high
and there were some indications of a
dose-response relation which will hope-
fully encourage further studies. To our
knowledge this is the first study to indicate
a relation between sarcoidosis and expo-
sure to the crystalline silica, cristobalite.
(Occup Environ Med 1998;55:657–660)
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Although the aetiology of sarcoidosis is un-
known, pulmonary sarcoidosis is mediated by
an intensive cellular immune response at sites
of disease activity.1 Sarcoidosis is a benign phe-
nomenon which often is only incidentally
discovered, as it tends to exhibit few symptoms
and thus goes undiscovered and may clear up
by itself without treatment. The diagnosis of
sarcoidosis is based on clinical symptoms and
signs, and pathological changes which are
compatible with sarcoidosis when other dis-
eases have been excluded.
A working group under the auspices of the
International Agency for Research on Cancer
(IARC) has recently evaluated carcinogenicity
from crystalline silica inhaled in the form of
quartz or cristobalite and reclassified these as
carcinogenic to humans, which is an upgrade
from their previous classification as probably
carcinogenic.2
In a recent communication the relation
between exposure to silica and some autoim-
mune diseases was discussed,3 with specific
reference to systemic sclerosis, rheumatoid
arthritis, lupus, and chronic renal disease. The
authors present some plausible mechanisms for
such an association from the medical literature
and they urge that further studies be carried
out on exposure to silica and autoimmune
conditions.
Over 10 years ago we presented what was
then little more than an indication that
sarcoidosis seemed to be more common in a
cohort exposed to crystalline silica in the form
of cristobalite.4 This cohort consisted of work-
ers employed in a plant processing diatoma-
ceous earth who had previously been studied
for the risk of lung cancer.5 The plant is located
in the northern part of Iceland and the health
surveillance of the workers was conducted at a
local, community based, primary healthcare
centre. This situation was considered ideal for
evaluating the relation between sarcoidosis and
exposure to diatomaceous earth and cristobal-
ite in a case-referent study.
Material and methods
The population of the district (about 4500 peo-
ple), which is served by the healthcare centre
and the hospital in the town of Husavik,
functioned as the study base. The people were
identified in the National register, which by law,
must be kept at the Statistical Bureau of Iceland
and consists of everyone who has lived in Iceland
since 1951. The healthcare centre and the
hospital, which are the only medical institutions
in the district, are responsible for the primary
and secondary health care of the population of
the district, including the workers at the
diatomaceous earth plant on Lake Myvatn.
Table 1 Characteristics of the cases
Cases
Age at
diagnosis Sex
Symptoms
at diagnosis Histology
x Ray
stage
1 23 Male Yes Yes II
2 34 Female Yes Yes III
3 34 Male No Yes III
4 42 Male No Yes III
5 32 Male No Yes I
6 25 Female Yes No I
7 52 Female No Yes II
8 42 Female Yes Yes 0
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Diatomaceous earth is material composed of
siliceous skeletons of microscopic plants, dia-
toms, large deposits of which are found on the
bottom of Lake Myvatn. The deposits are sev-
eral metres thick and are pumped up from the
lake and into the plant. The material is then
dried using geothermal water and sieved. On
further processing by flux-calcination, which
forms the principal part of the process, a large
portion of the diatomaceous earth is trans-
formed from an amorphous state to a crystal-
line form, which is up to 70% cristobalite and
1%–2% quartz.6
Information on the cases of sarcoidosis was
obtained from the files of the healthcare centre
and the hospital. Those selected had to meet
three of the following five criteria: (a) show
pulmonary or general symptoms, (b) show
parenchymal or lymph node changes on chest x
ray films, (c) have a histopathological diagnosis
compatible with sarcoidosis, (d) include ery-
thema nodosum, and (e) report the benign
course of the disease, with regression of
pulmonary and other symptoms and signs. All
cases selected were to meet this last criterion.
All cases except one fulfilled the third criterion
and that case had erythema nodosum. The his-
tology is characterised by non-caseating epithe-
lioid granulomas, but there are no pathogno-
monic features, thus the importance of the
benign course (the fifth criterion). The charac-
teristics of the cases are shown in table 1. The
referents were drawn randomly from the popu-
lation of the district from the National register.
We did not stratify on age, however, the age
range of the cases determined the age section of
the population register used to draw the refer-
ents. Permission to carry out the study was
obtained from the Data Protecting Commis-
sion.
The cases and referents were record linked
with a file which included all present and past
workers of the diatomaceous earth plant and
those who had worked at loading the finished
product from the plant aboard transport
vessels.5 This was possible through the 10-digit
personal identification number unique for
every Icelander; the same number is used in the
National register. In this way it could be ascer-
tained whether cases and referents had been
exposed to diatomaceous earth and crystalline
silica. The diatomaceous earth plant started
operations in 1967. In accordance with a
request from the public health authorities in
Iceland the management of the plant keeps files
on every worker at the plant. The files included
information on when the workers started and
stopped diVerent job tasks in the plant. Payrolls
were available for those who had worked at
loading vessels. Thus it was possible to obtain
information on how many hours each worker
had been exposed.
As the result of another initiative of the
health authorities the workers at the plant
underwent annual health check ups at the
healthcare centre in Husavik; however, chest x
ray films were only done every second or fifth
year since 1980. In general the exposed
workers were not considered to have more res-
piratory symptoms than others and those load-
ing vessels were not included in the health
check ups. No case of silicosis has yet been
diagnosed among the present or past workers.
Records of personal samples of respirable
cristobalite showed considerable variation ac-
cording to the person’s tasks and location
within the factory.6 The dust measurement of
personal samples from the year 1978 showed
mean values of 0.6, 0.3, 0.2, and 0.1 mg/m3 of
respirable cristobalite for packers, oven opera-
tors, maintenance men, and cleaners, respec-
tively. The average value for those loading
transport vessels was 0.3 mg/m3 according to
measurements from 1978. It is assumed that
the working conditions have improved since
then, yet the mean values of the content of
respirable cristobalite in personal samples was
0.02 mg/m3 in loading and 0.05, 0.002, 0.01,
and 0.06 mg/m3 for packers, oven operators,
maintenance men, and cleaners, respectively,
in the year 1981.6 The threshold limit value for
respirable cristobalite is 0.05 mg/m3, according
to the threshold limit value list in Iceland.7
Odds ratios (ORs) and 95% confidence
intervals (95% CIs) were calculated according
to Fisher’s exact test.8 Sarcoidosis is a disease
which can pass unnoticed without symptoms
and therefore it is possible that cases among the
exposed group were only found because of the
annual health examinations. To eliminate this
possible bias it was decided, after analysing all
the cases, to restrict the subsequent analysis of
the material to those which were not discovered
at the routine health examinations.
Table 2 Years of exposure, number of years from first exposure to diagnosis, year of
diagnosis and accumulated hours at exposed work
Cases
Start of
exposure
Last year of
exposure
First exposure to
diagnosis (y)
Year of
diagnosis
Accumulated
hours at work
1 1973 1973 1 1974 680
2 1970 1977 4 1974 396
3 1967 1981 10 1976 21120
4 1973 1981 10 1982 16040
5 1975 1978 10 1984 348
6 — — — 1989 0
7 1987 1992 6 1992 10720
8 — — — 1993 0
Table 3 All cases and referents according to exposure
to diatomaceous earth and cristobalite and cases not
discovered at routine health check up, incidental cases,
odds ratio (95% CI)
Exposed
Odds
ratio 95% CIEver Never
All cases:
Cases 6 2
Referents 13 57 13.2 2.0 to 140.9
Incidental cases:
Cases 4 2
Referents 13 57 8.8 1.1 to 102.5
Table 4 Cases which were not discovered at routine
examinations and referents according to exposure to
diatomaceous earth and cristobalite
Exposure (h)
>1000 <1000 Never
Cases 1 3 2
Referents 1 12 57
Odds ratios 28.5 7.1 (1)
95% CIs 0.24 to 2271.5 0.7 to 90.5
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Results
A total of eight cases were found, six of which
had been exposed to diatomaceous earth and
cristobalite at work. The six exposed cases were
distributed into diVerent job categories so no
particular job seemed at increased risk. Expo-
sure information and year of diagnosis of the
cases are shown in table 2.
Of the 70 referents 13 had been exposed.
The OR (95% CI) for all the cases and
referents are shown in table 3. In table 3 the
OR (95% CI) are shown after restricting the
study to those cases which were not discovered
at the annual health examinations. The OR was
still high.
Table 4 shows the cases not found at annual
health examinations and referents classified
into exposure categories according to accumu-
lated number of hours of exposure: those who
had worked >1000 hours, those who had
worked <1000 hours, and those who had never
been exposed to diatomaceous earth at work.
The only case who had worked >1000 hours
had indeed worked >10 000 hours. As the
numbers are low, the calculations give us wide
95% CIs. None the less, the ORs were high,
and increased with longer exposure.
Discussion
The ORs were increased for those who had
been exposed to diatomaceous earth and
cristobalite and there was an indication of a
dose-response relation. However, as there are
few cases the results are handicapped by wide
95% CIs.
Although it was not the purpose of this study
to find the annual incidence of sarcoidosis in
the health district concerned, this can be
estimated on the basis of the number of inhab-
itants, the number of years observed, and the
number of cases, producing an annual inci-
dence of 9.3/100 000. This is far higher than
the annual incidence of sarcoidosis for the
whole population of Iceland, which in the year
1978 was estimated to range from 0.5–2.7/
100 000.9
The main strength of the study is that the
exposure history was obtained by record
linkage of a joint file of cases and referents with
a file of all exposed people, which in turn was
obtained from employment lists from the
factory and payrolls from the shipping agency.
The file of the exposed workers was gathered
entirely independently of the diagnosis of the
cases. In this record linkage we used the
personal identification number which everyone
in Iceland has. Thus the information on expo-
sure was obtained independent of subjective
evaluation or memory of the cases and
referents, or of the doctors who were responsi-
ble for the diagnosis and treatment of the cases,
or of those performing the study.
The referents were selected randomly from
the population from which the cases were diag-
nosed. For this purpose we used the National
register, and the inhabitants of the district
served by the healthcare centre and hospital of
Husavik formed the study base. Thus the
method ensures that the referents are represen-
tative of the exposure rate in the population.
The discussion of the biological plausibility of
a relation between exposure to silica and
autoimmune conditions has already been
mentioned3 but the medical literature on silica
and sarcoidosis is scant. Cutaneous silica granu-
loma, which is diVerent from cutaneous sar-
coidosis, is known to develop in old scars
contaminated with silica in crystalline or vitre-
ous form.10 11 The suggestion has been made
that only granulomatous infiltration of an old
scar should be considered as scar sarcoidosis
when this is present along with other manifesta-
tions of sarcoidosis.11 According to a paper by
Eggelmeijer et al11 most patients with scar
sarcoidosis were found to have siliceous material
in the infiltrations, thus there are striking
similarities between scar sarcoidosis and silica
granuloma. In the light of this, the description of
a patient in whom silica granuloma progressed
into scar sarcoidosis is of interest.12
It has been postulated that silica granulomas
represent a delayed hypersensitivity response13
and it has also been suggested that silica may act
in a manner similar to beryllium and zirconium,
in causing a delayed hypersensitivity reaction
which may result in a histological picture identi-
cal to that of sarcoidosis.14 Previously the
clinical, histological, and radiological similarities
between beryllium disease and sarcoidosis have
been discussed15 and the importance of the
knowledge of occupational exposure to beryl-
lium has been stressed.15 The coexistence of
these two diseases is thought to be very unlikely
and the importance of increased tissue content
of beryllium in lung and mediastinal lymph
nodes has been reported.15 On the contrary, the
coincidence of silicosis and sarcoidosis has been
reported in a communication from Germany in
a case series,16 in which the pathogenesis of both
diseases is discussed.17 This communication by
Hubener et al also refers to several other case
reports on the association of silicosis and
sarcoidosis.16
Exposure to crystalline silica has been
suggested to have an eVect on the immune sys-
tem, which has drawn attention to the possible
association of exposure to silica and autoim-
mune diseases.3 Whether the immunological
role of silica may be the explanatory link in the
pathogenesis of the carcinogenic properties of
silica or not, will certainly continue to be the
focus of future research.18
A recent study has shown that the risk of sar-
coidosis was statistically associated with men
enlisted in the United States Navy to aircraft
carriers.19 The study was initiated by a man
who asked whether his sarcoidosis diagnosed in
1974 may have been associated with environ-
mental exposure during his service in the navy.
The diagnosis was based on a chest radiograph
indicating bilateral hilar adenopathy without
parenchymal disease and non-caseating granu-
lomata on lymph node biopsy. He related his
symptoms to his work of grinding antiskid
materials from aircraft carrier decks during the
preceding two years. In 1987 pneumoconiosis
was diagnosed in this patient after mineral dust
deposits were identified in a lung biopsy and
the mineral dust deposit were attributed to the
same work exposure aboard the aircraft
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carrier.19 The report does not give the precise
nature of the mineral concerned.19
If the association between exposure to
diatomaceous earth or cristobalite and sar-
coidosis is causal, it is an addition to our con-
stantly increasing knowledge on the compli-
cated eVect of silica on human health and will
further intensify the demand for control of
exposure.
In conclusion we have found an increased
risk of sarcoidosis among those workers
exposed to diatomaceous earth and cristobal-
ite. There is a biological plausibility for such an
association and the finding is interesting in
view of the fact that the assessment of the car-
cinogenic property of cristobalite has been
upgraded recently.
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Vancouver style
All manuscripts submitted to Occup Environ
Med should conform to the uniform require-
ments for manuscripts submitted to biomedi-
cal journals (known as the Vancouver style.)
Occup Environ Med, together with many
other international biomedical journals, has
agreed to accept articles prepared in accord-
ance with the Vancouver style. The style
(described in full in the JAMA[1]) is intended
to standardise requirements for authors, and is
the same as in this issue.
References should be numbered consecu-
tively in the order in which they are first men-
tioned in the text by Arabic numerals on the
line in square brackets on each occasion
the reference is cited (Manson[1] confirmed
other reports[2][3][4][5]). In future ref-
erences to papers submitted to Occup Environ
Med should include: the names of all
authors if there are three or less or, if there are
more, the first three followed by et al; the title
of journal articles or book chapters; the titles of
journals abbreviated according to the style of
Index Medicus; and the first and final page
numbers of the article or chapter. Titles not in
Index Medicus should be given in full.
Examples of common forms of references
are:
1 International Committee of Medical Journal Editors.
Uniform requirements for manuscripts submitted to
biomed journals. JAMA 1993;269:2282-6.
2 Soter NA, Wasserman SI, Austen KF. Cold urticaria:
release into the circulation of histmaine and eosinophil
chemotactic factor of anaphylaxis during cold challenge.
N Engl J Med 1976;294:687-90.
3 Weinstein L, Swartz MN. Pathogenic properties of invad-
ing micro-organisms. In: Sodeman WA Jr, Sodeman WA,
eds. Pathologic physiology, mechanisms of disease. Philadel-
phia: W B Saunders, 1974:457-72.
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